In addition, CD274-mediated neutralization of PD-L1 further enhanced the promotive effects of MRS-1706-mediated antagonization of A2BR on NK cell infiltration and cytotoxicity; therefore, A2BR antagonization along with PD-L1 neutralization can be a potential strategy for tumor therapy based on enhancing the NK cell function. Here, CD274 is linked to neoplasm.